Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Spectrumceuticals Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (41)
ARTG (32)
Listed medicine compliance report (1)

Date

2025 (8)
2024 (17)
2023 (7)
2022 (6)
2021 (12)
2020 (18)
2017 (3)
2016 (2)
2014 (1)

Search

Sponsor content

74 result(s) found, displaying 61 to 70

Buffered Magnesium Glycinate Cancelled under Section 30(1)(c) of the Act

28 October 2020

Cancellation by sponsor

Requested by Spectrumceuticals Pty Ltd
Zinc Citrate P5P Forte Cancelled under Section 30(1)(c) of the Act

27 May 2020

Cancellation by sponsor

Requested by Spectrumceuticals Pty Ltd
Zinc 25mg Cancelled under Section 30(1)(c) of the Act

22 May 2020

Cancellation by sponsor

Requested by Spectrumceuticals Pty Ltd
MagnEzinc P5P (Spectrumceuticals Pty Ltd)

8 May 2020

Listed medicine compliance report

Medicine is no longer permitted to be supplied (View full entry for advice on the safety of using this medicine.)
Zinc Citrate P5P Cancelled under Section 30(1)(c) of the Act

6 May 2020

Cancellation by sponsor

Requested by Spectrumceuticals Pty Ltd
Pro4-50 D-Lactate Free Powder Cancelled under Section 30(1)(c) of the Act

6 May 2020

Cancellation by sponsor

Requested by Spectrumceuticals Pty Ltd
BioOne L. Reuteri LRE02 Cancelled under Section 30(1)(c) of the Act

19 February 2020

Cancellation by sponsor

Requested by Spectrumceuticals Pty Ltd
MagnEzinc P5P Cancelled under Section 30(1)(c) of the Act

14 February 2020

Cancellation by sponsor

Requested by Spectrumceuticals Pty Ltd
SB 500 (227043)

19 August 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SB 500.
Pro6 Infant Cancelled under s30(1)(c)

15 June 2017

Cancellation by sponsor

Requested by Spectrumceuticals Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.